host
bacteria
virus
depend
olink
nlink
glycosyl
perform
vital
biolog
function
pathogen
often
integr
protein
particip
hostcel
interact
receptor
bind
fusion
host
membran
fusion
protein
broad
rang
dispar
virus
paramyxoviru
hiv
ebola
influenza
virus
share
varieti
common
featur
augment
glycosyl
virus
contain
multipl
glycosyl
site
must
process
modifi
host
posttransl
machineri
fusogen
activ
virus
glycosyl
play
role
biogenesi
stabil
antigen
infect
bacteria
glycosyl
event
play
import
role
format
flagellin
pili
vital
import
adher
attach
infect
immun
evas
import
glycosyl
pathogen
surviv
clear
better
understand
process
need
understand
pathogen
requir
glycosyl
capit
requir
develop
novel
therapeut
versita
sp
z
oo
glycom
rapidli
becom
emerg
field
import
understand
biolog
cell
glycom
organ
repertoir
glycan
modif
made
dna
lipid
protein
recent
signific
role
modif
appreci
believ
posttransl
modif
protein
provid
seri
uniqu
regulatori
function
activ
eukaryot
prokaryot
cell
accord
recent
review
witz
perhap
form
posttransl
modif
protein
modif
glycosyl
event
may
import
molecular
modif
cellular
protein
glycosyl
ubiquit
posttransl
event
glycan
attach
amino
side
chain
past
year
research
demonstr
glycosyl
essenti
cell
adhes
receptor
activ
signal
transduct
molecular
traffick
endocytosi
prokaryot
eukaryot
cell
differ
monosaccharid
amino
acid
involv
glycoprotein
assembl
glycosid
bond
known
link
glycan
protein
target
nlink
olink
clink
phosphoglycosyl
glypiat
event
four
type
glycosyl
describ
thu
far
nlink
olink
clink
newli
describ
cystein
slink
figur
common
form
regard
infecti
diseas
nlink
glycosyl
high
mannos
core
attach
amid
nitrogen
asparagin
context
conserv
motif
asnxserthr
modif
occur
earli
protein
synthesi
follow
complex
process
trim
remodel
culmin
transit
protein
endoplasm
reticulum
golgi
result
glycoprotein
complex
oligosaccharid
structur
nlink
glycosyl
import
fold
mani
protein
occur
wide
eukaryot
organ
rare
bacteria
virus
commonli
use
host
cell
process
modifi
protein
present
surfac
hostspecif
fashion
ultim
impact
viral
glycoprotein
role
stabil
antigen
host
cell
invas
olink
glycosyl
posttransl
modif
secret
membran
bound
protein
take
place
cisgolgi
compart
olink
glycan
play
import
role
protein
local
traffick
protein
solubl
antigen
cellcel
interact
modif
oxygen
serin
threonin
protein
occur
addit
nacetyl
galactosamin
galnac
oglycan
extend
long
chain
similar
nglycan
usual
less
branch
result
format
mucinlik
molecul
oglycan
function
lectinligand
interact
may
facilit
interact
cellular
protein
use
receptor
entri
viral
attach
protein
olink
rsvg
protein
clink
modif
repres
third
type
glycosyl
much
less
common
novel
clink
modif
result
attach
tryptophan
via
carbon
describ
glycosyl
viru
protein
n
olink
varieti
falzarano
et
al
demonstr
clink
modif
ebola
solubl
glycoprotein
repres
first
descript
cmannosyl
viral
protein
role
modif
eukaryot
system
fulli
clarifi
howev
first
describ
human
modif
also
exist
sever
innat
complement
compon
complement
regul
properdin
suggest
role
innat
defens
final
modif
sglycosyl
new
exceedingli
rare
posttransl
modif
found
glycopeptid
bacteriocin
sulfur
amino
acid
cystein
modifi
nacetylhexosmin
biolog
role
modif
still
investig
may
prove
uniqu
bacteriocin
given
scope
breadth
protein
modif
role
modif
play
physiolog
cell
surpris
potenti
pathogen
subvert
process
promot
replic
surviv
respect
bacteria
bodi
knowledg
regard
glycosyl
small
extens
repertoir
glycoconjug
bacteri
cell
surfac
includ
lipopolysaccharid
capsular
polysaccharid
glycoprotein
exopolysaccharid
name
molecul
found
gramneg
bacteria
group
surfac
layer
slayer
glycoprotein
gramposit
bacteria
also
exist
protein
glycosyl
initi
describ
long
believ
eukaryot
cell
singularli
capabl
glycosyl
twothird
protein
predict
modifi
glycosyl
clear
prokaryot
capabl
may
exhibit
greater
divers
glycan
composit
structur
eukaryot
continu
difficulti
understand
prokaryot
glycosyl
lie
inabl
proper
analysi
character
gener
sugar
employ
modif
eukaryot
protein
highli
conserv
contrast
sugar
util
produc
glycoprotein
prokaryot
cell
unusu
structur
may
difficult
analyz
technolog
develop
examin
protein
character
carbohydr
modif
also
includ
analysi
amino
acid
consensu
figur
schemat
represent
carbohydr
linkag
known
occur
pathogen
four
describ
carbohydr
linkag
display
divers
possibl
carbohydr
affix
amino
acid
nlinkag
employ
amid
nitrogen
asparagin
associ
consensu
sequenc
nxst
x
amino
acid
except
prolin
olinkag
util
hydroxyl
oxygen
serin
threonin
tyrosin
clinkag
result
carboncarbon
attach
tryptophan
within
consensu
sequenc
wxxw
first
tryptophan
becom
mannosyl
slinkag
repres
recent
describ
result
addit
hexnac
link
sulfur
termin
cystein
abbrevi
gal
galactos
glcnac
nacetylglucosamin
galnac
nacetylgalactosamin
hexnac
nacetylhexosamin
fucnac
nacetylfucosamin
man
mannos
rha
rhamnos
glc
glucos
gal
galactos
fuc
fucos
sequenc
carbohydr
addit
may
occur
eukaryot
nlink
glycosyl
consensu
sequon
asnxserthr
result
attach
carbohydr
peptid
backbon
thu
far
consensu
sequon
clearli
identifi
olink
addit
outsid
requir
serthr
residu
forti
year
discoveri
eukaryot
glycosyl
bacteri
slayer
shown
glycosyl
clostridium
speci
glycan
found
bacteri
slayer
often
olink
varieti
associ
serin
threonin
tyrosin
past
year
increas
understand
nand
olink
protein
glycosyl
system
current
campylobact
jejuni
bacterium
describ
well
character
nglycosyl
pathway
solubl
membran
protein
glycosyl
among
glycoconjug
found
bacteria
exampl
archeal
bacteri
slayer
flagella
pili
repres
carbohydr
addit
glucos
galactos
heptos
pseudamin
acid
high
mannos
nacetylhexosamin
nacetylglucosamin
carbohydr
modif
found
commens
pathogen
bacteria
intestin
symbiont
bacteroid
fragili
describ
system
oglycosyl
import
physiolog
organ
organ
develop
exquisit
adapt
gastrointestin
tract
compris
one
abund
speci
human
colon
bacteroid
complex
system
mechan
devot
acquisit
metabol
carbohydr
allow
organ
rapidli
adapt
shift
food
bacteroid
also
mechan
allow
captur
fucos
host
mucos
surfac
rare
bacteri
pathway
incorpor
exogen
fucos
bacteri
capsul
glycoprotein
pathogen
bacteria
also
demonstr
employ
glycosyl
standpoint
health
diseas
character
glycan
pathogen
bacteria
import
understand
pathobiolog
eventu
treatment
pathogen
bacterium
neisseria
one
first
exampl
oglycosyl
glycoprotein
human
pathogen
sever
studi
demonstr
gene
import
gener
pilin
glycan
mechan
involv
gramneg
bacteria
neisseria
produc
divers
array
pili
mediat
microbemicrob
hostpathogen
interact
import
develop
diseas
neisseria
meningitid
neisseria
gonorrhoea
make
use
unusu
sugar
trisaccharid
olinkag
serin
addit
neisseria
speci
also
evid
support
addit
olink
glycan
pseudamin
acid
serin
residu
analog
sialic
acid
pseudomona
aeruginosa
pili
flagellin
pathogen
helicobact
pylori
campylobact
coli
case
campylobact
least
serinethreonin
residu
surfac
expos
flagella
filament
modifi
pseudamin
acid
glycosyl
pilin
flagellin
mani
case
necessari
assembl
pili
flagella
becom
import
pathogenesi
infect
role
protein
play
mobil
colon
virul
addit
aforement
bacteri
speci
also
descript
carbohydr
addit
protein
borrelia
burdorferi
chlamydia
trachomati
escherichia
coli
mycobacterium
tuberculosi
contribut
attach
infect
tabl
scientif
commun
begin
appreci
bacteri
glycosyl
broad
uniqu
rang
sugar
found
prokaryot
glycoprotein
pathway
mechan
prokaryot
glycosyl
also
describ
continu
effort
clearer
understand
biolog
prokaryot
glycosyl
lead
enhanc
antibacteri
agent
present
role
glycosyl
bacteri
protein
twofold
first
mani
glycosyl
event
result
chang
protein
function
affect
assembl
flagellin
pili
increas
bacteri
adher
secondli
addit
carbohydr
protein
also
dramat
affect
interact
host
immun
system
studi
bacteri
glycosyl
made
difficult
lack
technolog
complex
bacteri
carbohydr
modif
develop
analyt
capac
coupl
intens
studi
descript
enzymat
pathway
bring
greater
underst
bacteri
glycan
develop
novel
therapeut
protein
glycosyl
vital
import
variou
stage
viru
life
cycl
initi
attach
termin
stage
viru
releas
standpoint
viru
use
model
system
better
understand
gener
mechan
protein
glycosyl
virus
minim
level
glycosyl
howev
variat
among
virus
quit
substanti
exampl
e
protein
dengu
two
put
site
virus
human
immunodefici
viru
borrelia
burgdorferi
glcnac
minor
protein
campylobact
pseudamin
acid
flagellin
mycobacterium
tuberculosi
mannos
fucos
surfac
escherchia
coli
heptos
tiba
neisseria
glcnac
pilin
pseudomona
aeruginosa
pseudamin
acid
pilin
flagellin
clostridium
hexnac
slime
layer
helicobact
pylori
pseudamin
acid
high
mannos
sialic
acid
flagellin
chlamydia
trachomati
high
manos
minor
protein
influenza
high
mannos
ha
lymphocyt
choriomening
viru
high
mannos
filoviru
glcnac
high
mannos
gp
rsv
glucosaminoglycan
g
high
mannos
fucos
hiv
heavili
glycosyl
averag
site
case
hiv
glycoprotein
highli
glycosyl
viral
protein
high
level
nlink
glycosyl
benefit
viru
serv
glycan
shield
protect
viru
host
immun
system
evolut
sugar
ad
delet
continu
bring
divers
complex
viral
glycoprotein
tabl
alter
abrog
site
glycosyl
dramat
impact
surviv
transmiss
mani
virus
small
alter
glycosyl
alter
fold
conform
turn
affect
entir
molecul
addit
chang
level
glycosyl
affect
interact
host
receptor
chang
glycosyl
level
also
caus
viru
readili
recogn
innat
host
immun
cell
thu
impact
viral
replic
infect
mani
virus
contain
glycosyl
protein
caus
human
anim
diseas
howev
review
illustr
purpos
focu
upon
two
medic
import
viru
famili
last
year
influenza
viru
orthomyxovirida
perhap
one
well
studi
virus
respect
level
function
aspect
glycosyl
sever
influenza
protein
clearli
demonstr
predict
carbohydr
modif
surfac
protein
hemagglutinin
ha
neuraminidas
na
use
glycosyl
varieti
import
function
includ
receptor
bind
infect
viru
releas
neurovirul
ha
major
antigen
surfac
glycoprotein
influenza
mediat
attach
entri
target
cell
tradit
believ
sialic
acid
sole
respons
mediat
entri
event
recent
studi
shown
nlink
glycosyl
mediat
sialic
acid
independ
attach
entri
cell
contain
surfac
resid
carbohydr
recognit
molecul
infect
ha
undergo
posttransl
glycosyl
indispens
proper
fold
traffick
molecul
infect
number
site
describ
rang
site
site
within
stalk
region
molecul
remain
rel
invari
sinc
vital
proper
fold
process
molecul
clear
influenza
monument
effect
global
health
remain
persist
threat
three
pandem
occur
th
centuri
accumul
estim
million
million
million
death
respect
predict
level
glycosyl
pandem
strain
site
site
site
present
commonli
circul
strain
result
approxim
death
year
mostli
within
immunocomprom
elderli
popul
last
year
gradual
increas
site
potenti
glycosyl
increas
actual
glycosyl
abe
et
al
introduc
site
glycosyl
site
direct
mutagenesi
pandem
hong
kong
strain
result
addit
carbohydr
anecdot
evid
recent
studi
would
also
indic
accumul
carbohydr
lead
attenu
diseas
mous
model
infect
studi
show
glycosyl
increas
diseas
attenu
part
due
improv
recognit
clearanc
lung
surfact
associ
proteind
spd
illustr
addit
carbohydr
posit
detriment
effect
viru
recent
swine
predict
fewer
site
glycosyl
contemporari
strain
shown
experiment
singl
sequon
nlink
glycosyl
globular
head
compar
season
carri
sequon
interestingli
studi
suggest
loss
nglycosyl
led
resist
spd
mannos
bind
lectin
mbl
activ
locat
posit
glycosyl
critic
affect
activ
ha
either
deleteri
advantag
manner
exampl
cleavag
ha
host
proteas
vital
viru
entri
therefor
affect
determin
tissu
tropism
viral
virul
carbohydr
posit
proxim
ha
cleavag
site
prevent
proteas
access
limit
viru
entri
site
unoccupi
carbohydr
altern
klenk
et
al
illustr
carbohydr
posit
near
receptor
bind
site
necessari
effici
replic
releas
viru
carbohydr
posit
around
globular
head
mask
antigen
site
immun
recognit
believ
mechan
antigen
drift
virus
recent
da
et
al
examin
role
glycosyl
antigen
drift
within
globular
domain
show
number
glycosyl
site
globular
head
influenc
overal
variat
antigen
region
rather
variat
occur
region
unshield
glycosyl
conclud
glycosyl
gener
shield
viru
antibodymedi
recognit
evid
view
came
earlier
studi
success
ad
addit
asnxserthr
site
potenti
glycosyl
sitedirect
mutagenesi
reveal
viru
could
evad
host
respons
without
neg
impact
surviv
biolog
activ
addit
increas
carbohydr
onto
globular
head
ha
molecul
virus
result
decreas
receptor
bind
effect
fusion
activ
suggest
neg
impact
function
convers
addit
glycan
globular
head
ha
inde
affect
receptor
bind
fusion
activ
effect
glycan
addit
especi
import
look
interact
ha
na
show
balanc
need
receptor
bind
activ
viru
releas
overal
ha
depend
balanc
glycosyl
promot
proper
protein
fold
facilit
interact
viru
receptor
elicit
effici
particl
releas
although
mani
viru
glycoprotein
contain
nlink
glycan
extens
modifi
olink
glycosyl
one
exampl
respiratori
syncyti
viru
attach
rsv
g
protein
rsv
paramyxovirida
perhap
import
caus
viral
lower
respiratori
tract
infect
infant
children
worldwid
rsv
also
caus
sever
diseas
death
among
older
person
person
age
compromis
respiratori
cardiac
immun
system
exacerb
chronic
cardiac
pulmonari
condit
membran
protein
new
emerg
virus
hendra
nipah
metapneumoviru
sarscov
also
shown
modifi
glycan
play
vital
role
viral
infect
protein
fold
tropism
protein
process
immun
evas
interestingli
case
nipah
viru
glycosyl
play
dual
role
glycosyl
lead
enhanc
resist
antibodi
neutral
yet
caus
reduct
membran
fusion
viral
entri
doubl
strand
rna
viru
high
mutagen
capac
viru
retrovirida
famili
virus
contain
multipl
subtyp
clade
distinguish
wide
intraclad
variat
envelop
protein
one
natur
heavili
glycosyl
protein
nlink
glycan
addit
vital
proper
function
envelop
glycoprotein
envelop
occur
trimer
complex
monom
associ
transmembran
viral
envelop
anchor
contain
averag
nlink
sequon
nxst
extens
glycosyl
shown
envelop
glycan
immunodefici
viru
almost
entir
compos
oligomannos
creat
impress
glycan
shield
implic
develop
vaccin
design
earli
studi
suggest
loss
glycan
diminish
bind
abrog
interact
viru
consequ
reduc
interact
cell
infect
cytopath
effect
reduc
littl
consequ
replic
clear
structur
chang
result
glycosyl
play
signific
role
pathogenesi
neutral
antibodi
one
main
adapt
compon
immun
respons
pathogen
role
neutral
antibodi
respons
clear
recent
studi
suggest
enhanc
resist
viru
antibodi
neutral
time
accompani
chang
variabl
loop
chang
potenti
glycosyl
contribut
nglycan
protect
question
remain
open
sinc
mani
glycan
highli
conserv
compon
exampl
neutral
human
monoclon
antibodi
target
epitop
contain
high
oligomannos
analysi
region
calares
et
al
illustr
import
oligomannos
neutral
antibodi
activ
conserv
epitop
suggest
function
role
infect
specul
relat
mannosedepend
attach
innat
surfac
molecul
mannos
receptor
mmr
dendrit
cellspecif
grab
nonintegrin
dcsign
lectin
could
facilit
entri
host
cell
suggest
escap
viru
often
contain
addit
nlink
glycan
posit
tradit
neutral
epitop
find
suggest
glycan
addit
provid
mechan
antibodi
evas
provid
protect
neutral
antibodi
howev
multipl
mutat
requir
frost
et
al
suggest
viral
escap
neutral
antibodi
promot
accumul
multipl
amino
acid
within
individu
evolv
glycan
shield
produc
repres
one
mechan
viral
persist
despit
increas
antibodi
repertoir
emerg
virus
repres
one
current
concern
zoonot
infect
becom
preval
recent
strong
push
explor
biolog
sever
emerg
virus
import
human
diseas
typic
virus
resid
wild
anim
reservoir
transmit
human
via
exposur
blood
excrement
bite
arenavirida
envelop
singl
strand
rna
virus
typic
spread
human
rodent
infect
famili
virus
caus
spectrum
mild
sever
lifethreaten
system
neurolog
infect
arenavirus
classifi
base
antigen
properti
two
group
old
world
lassa
viru
lymphocyt
choriomening
viru
lcmv
new
world
junin
machupo
sever
south
american
hemorrhag
fever
virus
consider
focu
direct
better
understand
role
glycosyl
arenavirus
prototyp
arenaviru
lcmv
contain
potenti
site
glycan
addit
glycoprotein
bonhomm
et
al
demonstr
site
occupi
site
occupi
studi
mutagenesi
site
perform
examin
effect
viral
fusion
infect
protein
process
result
suggest
high
level
conserv
site
nglycosyl
presenc
glycan
vital
import
protein
express
process
viral
infect
cell
fusion
mutagenesi
sever
site
abrog
function
gp
alter
process
overal
infect
filovirus
ebola
viru
caus
sever
hemorrhag
fever
human
nonhuman
primat
filovirus
neg
strand
nonseg
rna
genom
encod
seven
protein
ebola
surfac
glycoprotein
gp
highli
glycosyl
half
molecular
weight
attribut
nand
olink
glycan
entri
ebola
requir
gp
initi
attach
fusion
host
membran
earlier
studi
glycoprotein
suggest
protein
involv
adher
downregul
surfac
receptor
major
histocompat
complexi
mhci
suggest
innat
respons
viru
infect
would
blunt
dowl
et
al
studi
antigen
immunogen
ebola
viru
gp
gener
mutat
site
nlink
glycosyl
studi
perform
mutat
eight
site
nlink
glycosyl
one
effect
antigen
addit
result
demonstr
clear
differ
antibodi
respons
among
mutat
valu
glycosyl
ebola
shown
involv
glycosyl
antigen
studi
whole
suggest
may
possibl
enhanc
immun
ebola
via
specif
chang
gp
glycosyl
hantavirus
member
bunyavirda
famili
arthropodborn
anim
infect
virus
virus
famili
isol
transmit
arthropod
howev
hantavirus
except
rodent
born
transmit
human
exposur
aerosol
urin
fece
two
membran
glycoprotein
gn
gc
hantaviru
modifi
glycosyl
collect
protein
contain
six
potenti
site
attach
nlink
glycan
shi
elliott
demonstr
five
six
site
util
provid
proper
fold
process
intracellular
traffick
glycoprotein
recent
studi
shown
role
nlink
glycosyl
cell
fusion
extend
work
perform
shi
elliott
addit
mutagenesi
perform
make
singl
multipl
mutat
site
glycosyl
result
indic
one
specif
site
found
crucial
cell
fusion
low
ph
condit
indic
like
fusion
protein
hantaviru
research
late
clearli
demonstr
glycosyl
critic
import
pathobiolog
bacteri
viral
infect
equal
import
role
innat
immun
recognit
molecul
contribut
clearanc
pathogen
clearanc
mani
case
depend
level
type
protein
glycosyl
innat
immun
system
organ
contain
cell
resid
solubl
carbohydr
bind
protein
capabl
bind
nonself
carbohydr
structur
within
immun
system
sever
class
receptor
exist
recogn
target
glycan
structur
display
pathogen
organ
receptor
either
secret
microenviron
maintain
surfac
immun
cell
extens
studi
larg
famili
calciumdepend
molecul
call
ctype
lectin
receptor
clr
ctype
lectin
specif
protein
contain
termin
mannos
fucos
galactos
residu
mani
clr
molecul
restrict
antigen
present
cell
dendrit
cell
macrophag
bcell
although
also
found
natur
killer
cell
endotheli
cell
molecul
solubl
cellassoci
macrophag
mannos
receptor
mmr
macrophag
associ
macrophag
associ
receptor
collagen
origin
marco
dendrit
cellspecif
grab
nonintegrin
dcsign
demonstr
particip
recognit
clearanc
glycosyl
pathogen
molecul
repres
import
sentinel
within
respiratori
reproduct
gastrointestin
tract
play
vital
role
sens
recognit
glycan
diverg
organ
bacteria
yeast
virus
helminth
molecul
serv
first
line
defens
initi
adapt
immun
respons
particip
clearanc
process
pathogen
recognit
glycan
structur
result
intern
process
pathogen
packag
antigen
mhci
ii
therefor
clr
molecul
function
pathogen
recognit
receptor
induc
antigen
present
tcell
respons
figur
addit
capac
recogn
clear
pathogen
invad
molecul
particip
cell
signal
relay
inform
specif
pathogen
immun
system
activ
cytokin
express
program
although
role
clr
molecul
recogn
clear
pathogen
sever
pathogen
util
molecul
vehicl
bind
entri
target
effort
modul
immun
respons
exampl
two
recent
studi
suggest
mmr
repres
import
receptor
viru
entri
influenza
hiv
typic
one
would
suppos
virus
encount
molecul
would
remov
mucos
environ
destroy
howev
influenza
viru
hiv
report
use
cell
resid
carbohydr
recognit
molecul
receptor
entri
mycobacterium
tuberculosi
contain
high
mannos
residu
cell
wall
compon
target
mmr
dcsign
elicit
product
antiinflammatori
cytokin
addit
helicobact
pylori
produc
glycan
target
clr
molecul
alter
dendrit
cell
respons
activ
thelper
type
cell
net
effect
suppress
immun
activ
find
import
sinc
engag
receptor
particip
endocyt
phagocyt
process
may
provid
direct
rout
pathogen
entri
provid
ad
advantag
evas
innat
recognit
clearanc
sever
immun
cell
surfac
receptor
demonstr
import
entri
hcv
host
cell
particular
hcv
envelop
protein
found
associ
dcsign
relat
liver
lectin
lsign
oligomannos
nglycan
suggest
mechan
liver
dendrit
cell
tropism
illustr
two
novel
hcv
bind
receptor
glycosyl
west
nile
viru
wnv
dengu
prm
e
protein
suffici
promot
interact
uptak
dcsign
dcsign
receptor
dcsignr
davi
et
al
show
wnv
protein
modifi
glycan
bind
dcsign
dcsignr
demonstr
prefer
dcsignr
lin
et
al
shown
ebola
viru
glycoprotein
oligomannos
interact
dcsignr
wherea
glycoprotein
complex
glycan
mmr
dcsign
shown
bind
transmit
hiv
tcell
via
interact
envelop
glycoprotein
sarscov
protein
filoviru
glycoprotein
interact
liver
lymph
node
sinusoid
endotheli
cell
ctype
lectin
lsectin
enhanc
infect
lsectin
cellassoci
lectin
map
chromosom
locu
dcsign
coexpress
liver
lymph
node
recent
studi
lsectin
also
shown
molecul
interact
dcsign
promot
hcv
bind
util
clr
molecul
mmr
dcsign
dcsignr
lsectin
recognit
clearanc
activ
immun
system
import
compon
defens
strategi
infect
equal
clear
mani
recent
studi
strongli
suggest
pathogen
take
advantag
molecul
attach
entri
modif
immun
respons
role
glycosyl
pathobiolog
infect
defens
infect
complex
warrant
continu
investig
import
glycosyl
pathogen
protein
function
clear
last
sever
year
role
glycosyl
varieti
process
diseas
expand
consequ
import
role
pathobiolog
mani
investig
prompt
explor
plant
bacteri
algal
deriv
lectin
potenti
therapeut
avenu
research
especi
import
given
scarciti
effect
antivir
compound
treat
infect
medic
establish
mani
viabl
therapeut
agent
treatment
bacteri
infect
although
need
grow
age
antibiot
resist
develop
effect
agent
bacteri
pathogen
may
lag
tool
avail
better
character
bacteri
glycan
asid
numer
antivir
exist
antivir
compound
remaind
viral
infect
given
conserv
glycosyl
among
virus
import
role
glycan
life
cycl
clear
fruit
area
investig
sever
compound
classifi
carbohydr
bind
agent
cba
show
promis
inhibit
viru
activ
includ
cyanobacteri
cyanovirinn
cvn
plant
lectin
urtica
dioica
agglutinin
galanthu
nivalia
concanavalin
pradimycin
interfer
attach
neutral
hcv
influenza
viru
vitro
bertaux
et
al
show
sever
agent
select
inhibit
bind
entri
hcv
hiv
unabl
affect
herp
simplex
rsv
virus
recent
protein
red
alga
griffithsia
shown
bind
oligomannos
nlink
glycan
surfac
hiv
extrem
high
affin
prevent
entri
primari
isol
laboratori
strain
tand
mtropic
pathogen
yellow
sphere
contain
carbohydr
residu
interact
carbohydr
recognit
domain
cell
resid
crl
molecul
red
rectangl
upon
engag
crl
sever
biolog
process
occur
stimul
immun
system
first
signal
transduct
pathway
activ
secret
regulatori
cytokin
activ
adapt
immun
respons
repres
blue
star
second
engag
carbohydr
pathogen
surfac
result
intern
pathogen
process
compart
turn
packag
antigen
mhcii
molecul
third
case
crl
receptor
entri
pathogen
seen
influenza
salmonella
mycobacterium
pathogen
escap
degrad
compart
util
cell
host
replic
process
replic
pathogen
protein
captur
present
mhci
molecul
packag
pathogen
compon
bind
pocket
mhci
mhcii
activ
adapt
immun
respons
clearanc
exampl
avenu
treatment
current
explor
util
natur
product
treat
viral
infect
sever
group
success
use
antimalari
drug
chloroquin
hydroxychloroquin
combin
therapi
reduc
viral
load
hiv
patient
drug
limit
use
manag
malaria
mechan
action
repurpos
treat
diseas
infect
naard
et
al
perform
studi
illustr
use
chloroquin
reduc
transfer
viru
dcsign
lymphocyt
data
studi
strongli
suggest
viabl
mean
limit
viru
transmiss
replic
vivo
vitro
studi
sarscov
influenza
conjunct
field
success
drug
hiv
suggest
approach
appli
glycosyl
virus
sinc
action
chloroquin
interfer
viral
life
cycl
sever
stage
chloroquin
may
import
futur
therapi
viral
infect
sever
reason
first
drug
accumul
endosom
prevent
acidif
critic
process
mani
virus
lead
uncoat
releas
host
cell
cytoplasm
second
chloroquin
interfer
activ
glycosyltransferas
er
golgi
result
improp
carbohydr
addit
lack
associ
chaperon
protein
calnexin
calreticulin
third
pharmacolog
drug
well
describ
sinc
use
antimalari
year
recent
studi
suggest
chloroquin
effect
treatment
influenza
vitro
although
effect
vivo
ferret
model
infect
ineffect
vivo
may
attribut
level
drug
present
lung
follow
oral
administr
possibl
vivo
antivir
activ
improv
chang
rout
administr
nebul
inhal
deliv
drug
directli
mucosa
lung
base
field
success
chloroquin
hiv
infect
low
cost
gener
safeti
drug
chloroquin
could
reason
prophylact
therapi
varieti
acut
viral
infect
viru
reli
glycosyl
viru
assembl
protein
function
studi
glycosyl
diseas
remain
rel
new
area
investig
grow
bodi
knowledg
describ
role
carbohydr
cancer
infecti
diseas
diabet
chronic
liver
diseas
futur
therapeut
sever
fold
first
expand
group
carbohydr
bind
agent
show
util
compound
develop
effect
drug
envelop
virus
new
antivir
therapeut
broad
rang
envelop
virus
oligosaccharid
rich
membran
glycoprotein
come
field
pharmacognosi
pharmacognosi
scienc
physic
chemic
biochem
biolog
properti
compound
deriv
natur
origin
drug
natur
origin
could
well
becom
futur
treatment
infecti
diseas
second
develop
imino
sugar
interfer
glycosyl
enzym
shown
promis
viral
infect
difficulti
compound
although
molecul
broad
antivir
activ
develop
limit
issu
efficaci
andor
select
work
need
modifi
compound
better
target
pathogen
futur
compound
potenti
power
tool
manag
diseas
final
import
consider
futur
better
understand
interact
glycosyl
pathogen
protein
lectin
innat
immun
system
asid
jaw
vertebr
anim
kingdom
reli
innat
immun
defens
use
carbohydr
recogn
molecul
mbl
mmr
dcsign
defend
infect
scientif
literatur
continu
describ
glycosyl
pathogen
import
innat
molecul
play
greater
role
understand
infect
potenti
therapi
